(3S,4r)-4-[4-(benzyloxy)phenyl]-3-(4-fluorophenyl)1-[(s)-1-(4-methoxyphe Nyl)Ethyl]Azetidin-2-One

Jin-Chang Wu,Jing-Bo Sun,Xian-Xiu Xu

DOI: https://doi.org/10.1107/s160053680702096x

2007-01-01

Abstract:The title compound, C31H28FNO3, is an intermediate in the synthesis of ezetimibe analogues. The absolute configuration has been established on the basis of an unchanging chiral centre in one reactant.

What problem does this paper attempt to address?

1-Dehydroabietyl-4,5-diphenyl-1h-imidazole

Dawei Jiang,Min Hong,Fei Qiu,Jin Zhu,Lequn Huang

DOI: https://doi.org/10.1107/s1600536807035878

2007-01-01

Abstract:The title compound [systematic name: 1-(7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-ylmeth- yl)-4,5-diphenyl-1H-imidazole], C35H40N2, was obtained via the one-pot three-component condensation of benzil, formaldehyde and dehydroabietylamine, which is a fungal toxin. The two substituent phenyl groups and the imidazole ring form a conjugated system. The dihedral angles between the imidazole ring and the phenyl rings are 70.18 (9) and 12.77 (12)degrees. In the crystal structure, there are one intramolecular and two intermolecular hydrogen-bonding C-H center dot center dot center dot pi contacts. Furthermore, a weak C-H center dot center dot center dot N intramolecular hydrogen bond is observed.
(3r,4s)-1-(4-Methoxyphenyl)-2-Oxo-4-(3-Vinylphenyl) Azetidin-3-Yl Acetate

Xiao-Dong Hao,Cheng Xie,Yun-Peng Hao,Jun Chang,Xun Sun

DOI: https://doi.org/10.1107/S1600536813007897

2013-01-01

Abstract:In the title compound, C20H19NO4, the absolute configuration (3R, 4S) for the two chiral centres of the molecule has been determined.
Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

chao wu,yanjun guo,xiaolong zhang,aibao xia

DOI: https://doi.org/10.1080/15421406.2014.928446

IF: 0.7

2015-01-01

Molecular Crystals and Liquid Crystals

Abstract:The title compound, (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one, was synthesized and characterized by H-1 and C-13 NMR and HRMS spectroscopy. Its absolute molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type O-H horizontal ellipsis O. The methyl group and chlorophenyl group are located in the cis configuration. The conformation is stabilized by weak intermolecular C-H... O interactions.
(3S*,4s*)-1,3,4-triphenylazetidin-2-one

CC Luo,HX Zhang,TX Wu

DOI: https://doi.org/10.1107/s1600536805035063

2005-01-01

Abstract:In the crystal structure of the title compound, C21H17NO, the nitrogen configuration is almost planar.
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

N Xue,YZ Hu

DOI: https://doi.org/10.1107/s1600536805042005

2005-01-01

Abstract:The structure of the title compound, C30H33N3O10, consists of an almost planar imidazolin-2-one system connecting two planar substituted phenyl groups and a roughly planar 3,4,5-trimethoxyanilinocarbonyl fragment which forms a dihedral angle of 95.17 (9)degrees with the heterocyclic ring.
(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/S1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
New Synthesis Process for the Synthesis of Ezetimibe

余长泉,杨健

DOI: https://doi.org/10.3969/j.issn.1003-9015.2012.06.018

2012-01-01

Abstract:Ezetimibe is a novel selective cholesterol absorption inhibitor which was developed by both Schering-Plough and Merck. An improved process for the preparation of ezetimibe was studied and was described as follows. N-(4-(benzyloxy)benzylidene)-4-fluorobenzenamine (Compound 2) was prepared from 4-hyd-roxybenzaldehyde, 4-fluorobenzenamine and benzyl chloride in one pot. 5-(4-Fluorophenyl)-5-oxopentanoic acid was reacted with pivaloyl chloride and directly condensed with (S)-4-phenyloxazolidin-2-one promoted with LiCl, and then reduced by CBS/BH3 to get (4S)-3-[(5S)-5-(4-fluoror)-5-hydrox-1-oxo-pentyl]-4-phenyl-oxazolidin-2-one (Compound 4). It was condensed with compound 2 catalyzed with Lewis acid after being protected by TMS to afford the condensation intermediate. Finally it was cyclized by TBAF·3H2O and deprotected with Pd/C to get the title compound with a total yield of 56%. Compared with the current technology, the present process shows advantage in high yield, less raw material consumed, and easy production on industrial scale. The specific rotation and melting point of the prepared title compound is the same as that reported in literature,and the structure of the prepared title compound and some intermediates were confirmed by MS and 1H-NMR.
N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

Huo Ming Li,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810014996

2010-01-01

Abstract:The title compound, C(21)H(17)BrN(2)O(4), a 2-phenoxy-2-phenyl-acetamide derivative, exhibits a stereogenic center but crystallizes as a racemate as indicated by the centrosymmetric space group. In the molecular structure, the nitro-substituted benzene ring is coplanar [dihedral angle = 12.9 (1)degrees] with the plane formed by H-N-C(=O)-C=O due to intramolecular N-H center dot center dot center dot O hydrogen-bond interactions.
(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Yong-Zhou Hu,Hua-Zhou Ying

DOI: https://doi.org/10.1107/s1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

Zhang Jun-Liang,Lv Zhi-Liang,Zhong Jia-Liang,Chen Dai-Jie,Li Mo-Ying,Zhang Jian-Bin

DOI: https://doi.org/10.14102/j.cnki.0254-5861.2011-1561

IF: 0.847

2017-01-01

Chinese journal of structural chemistry

Abstract:The title compound (2S,3S,E)-4-(3,4-dihydroxybenzylidene)-3-(3,4-dihydroxy-phenyl)-5-oxotetrahydrofuran-2-carboxylic acid was synthesized and the 2D structure was characterized by H-1-NMR C-13-NMR and LCMS. The absolute configuration was determined by single-crystal X-ray diffraction of the key intermediate (2S,3S,E)-ethyl 4-(3,4-dimethoxybenzylidene)- 3-(3,4-dimethoxyphenyl)-5-oxotetrahydrofuran-2-carboxylate. The crystal belongs to tetragonal system, space group P4(1) with a = 13.0665(2), b = 13.0665(2), c = 13.4735(2) angstrom, V = 2300.4(6) angstrom(3), Z = 4, D-c = 1.278 g/cm(3), mu(CuK alpha) = 0.801 mm(-1), F(000) = 936, S = 1.050, R = 0.0364 and wR (I > 2 sigma(I)) = 0.1071. X-ray diffraction results showed that the molecular structure is stabilized totally by Van der Waals force. The antibacterial activity tests showed that the title compound possesses slight synergistic effect against MRSA and Acinetobacter baumanii.
2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-n-phenylbenzamide

J Wu,MF Chen,LH Wang,PZ Zhang

DOI: https://doi.org/10.1107/s1600536805032940

2005-01-01

Abstract:The title compound, C19H17N3O3S, was synthesized via the reaction of 2-(4,6-dimethoxypyrimidin-2-ylsulfanyl) benzoic acid and aniline in dichloromethane using dicyclohexylcarbodiimide as catalyst. The dihedral angles between the pyrimidine plane and the planes of the two benzene rings are 71.2 (2) and 62.7 (2)degrees; the dihedral angle between the planes of the two benzene rings is 68.4 (4)degrees. The conformation of the compound is U-shaped.
N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Jia-Lu Luo,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809028712

2009-01-01

Abstract:In the title compound, C(29)H(27)N(3)O(5), a dibenz[b,f][1,4]oxazepine derivative, the cyclo-hexane ring adopts a chair conformation, the oxazepine seven-membered ring has a twist-boat conformation, and the piperidin-2-one ring assumes a flattened boat conformation. Inter-molecular N-H⋯O hydrogen bonding between imino and nitro groups links two mol-ecules into a centrosymmetric dimer.
N-(2-Bromophenyl)-2-(4,6-Dimethoxy-Pyrimidin-2-Yloxy)Benzylamine

J Wu,PZ Zhang,QS Yu,XR Hu,JM Gu

DOI: https://doi.org/10.1107/s160053680301852x

2003-01-01

Abstract:The title compound, C19H18BrN3O3, was synthesized by the reaction of 2-methanesulfonyl-4,6-dimethoxypyrimidine and N-(2-bromophenyl)-2-hydroxybenzylamine in tetrahydrofuran. There are three different planes in the molecule, each of which is conjugated. The dihedral angles between the pyrimidine plane and the planes of the two phenyl rings are 107.85 (4) and 77.38 (2) degrees, and the dihedral angle between the planes of the two phenyl rings is 103.15(3)degrees.
(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

Bo Chao,Xing-Hai Wang,Jian Sun,Zhui-Bai Qiu

DOI: https://doi.org/10.1107/s1600536810013425

2010-01-01

Abstract:The crystal structure of the title compound, C(16)H(26)NO(2) (+)·C(18)H(13)O(8) (-), is stabilized by an extensive network of classical N-H⋯O and O-H⋯O hydrogen bonding. The crystal structure also shows an ammonium-driven diastereo-isomerism.
Ethyl 3-Bromo-1-(3-chloropyridin-2-yl)-1h-pyrazole-5-carboxylate

Hai-Bing He,Shan Liu,Hai-Jun Tan,Ming Xia,Hong-Jun Zhu

DOI: https://doi.org/10.1107/s1600536808039329

2009-01-01

Abstract:The title compound, C11H9BrClN3O2, is an intermediate in the synthesis of Rynaxypyre, a new insecticidal anthranilic diamide used as a potent and selective ryanodine receptor activator. The dihedral angle between the aromatic ring planes is 78.7 (2)°.
6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

JX Xu,S Jin,ZY Zhang,TCW Mak

DOI: https://doi.org/10.1107/s0108270198005630

1998-01-01

Acta Crystallographica Section C Crystal Structure Communications

Abstract:The title compound, C31H24ClNO2S, has a cis-ring-fusion tricyclic structure, which is formed from a benzene ring, a seven-membered heterocyclic thiazepine ring and a 1,3-oxazinone ring. The 1,5-thiazepine ring has a slightly distorted boat-like conformation, whereas the 1,3-oxazinone ring adopts a half-chair conformation.
(4R,5s)-Methyl 1,3-Dibenzyl-5-[(r)-2-(hydroxydiphenylmethyl)pyrrolidine-1-carbonyl]-2-o Xoimidazolidine-4-Carboxylate

Jian Liu,Fen-Er Chen,Min-Qin Chen

DOI: https://doi.org/10.1107/s1600536807045874

2007-01-01

Abstract:The title compound, C37H37N3O5, was synthesized as a key intermediate in the total synthesis of d-biotin and was crystallized from 2-propanol. It contains one chiral center in the pyrrole ring, where the absolute configuration is known from the synthesis, and from which the two other chiral centers in the imidazolidine ring could be determined. An intramolecular O—H⋯O and intermolecular C—H⋯O hydrogen bonds help to construct the three-dimensional network.
1,3A,5-Triphenyl-3a,4,5,6-tetrahydro-1,2,4-oxadiazolo[4,5-a][1,5]benzodiazepine

JX Xu,S Jin

DOI: https://doi.org/10.1107/s0108270199006575

1999-01-01

Acta Crystallographica Section C Crystal Structure Communications

Abstract:The title compound, C28H23N3O, has a cis ring-fusion tricyclic structure, which is formed from a benzene ring, a seven-membered heterocyclic diazepine ring and a 1,2,4-oxadiazole ring. The 1,5-diazepine ring has a slightly distorted boat-like conformation, whereas the 1,2,4-oxadiazole ring adopts an envelope conformation.

(3S,4r)-4-[4-(benzyloxy)phenyl]-3-(4-fluorophenyl)1-[(s)-1-(4-methoxyphe Nyl)Ethyl]Azetidin-2-One

1-Dehydroabietyl-4,5-diphenyl-1h-imidazole

(3r,4s)-1-(4-Methoxyphenyl)-2-Oxo-4-(3-Vinylphenyl) Azetidin-3-Yl Acetate

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(3S,4s)-1,3,4-triphenylazetidin-2-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

New Synthesis Process for the Synthesis of Ezetimibe

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-n-phenylbenzamide

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

N-(2-Bromophenyl)-2-(4,6-Dimethoxy-Pyrimidin-2-Yloxy)Benzylamine

(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

Ethyl 3-Bromo-1-(3-chloropyridin-2-yl)-1h-pyrazole-5-carboxylate

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

(4R,5s)-Methyl 1,3-Dibenzyl-5-[(r)-2-(hydroxydiphenylmethyl)pyrrolidine-1-carbonyl]-2-o Xoimidazolidine-4-Carboxylate

1,3A,5-Triphenyl-3a,4,5,6-tetrahydro-1,2,4-oxadiazolo[4,5-a][1,5]benzodiazepine

(3S,4r)-4-[4-(benzyloxy)phenyl]-3-(4-fluorophenyl)1-[(s)-1-(4-methoxyphe Nyl)Ethyl]Azetidin-2-One

1-Dehydroabietyl-4,5-diphenyl-1h-imidazole

(3r,4s)-1-(4-Methoxyphenyl)-2-Oxo-4-(3-Vinylphenyl) Azetidin-3-Yl Acetate

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(3S*,4s*)-1,3,4-triphenylazetidin-2-one

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

New Synthesis Process for the Synthesis of Ezetimibe

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-n-phenylbenzamide

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

N-(2-Bromophenyl)-2-(4,6-Dimethoxy-Pyrimidin-2-Yloxy)Benzylamine

(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

Ethyl 3-Bromo-1-(3-chloropyridin-2-yl)-1h-pyrazole-5-carboxylate

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

(4R,5s)-Methyl 1,3-Dibenzyl-5-[(r)-2-(hydroxydiphenylmethyl)pyrrolidine-1-carbonyl]-2-o Xoimidazolidine-4-Carboxylate

1,3A,5-Triphenyl-3a,4,5,6-tetrahydro-1,2,4-oxadiazolo[4,5-a][1,5]benzodiazepine

(3S,4s)-1,3,4-triphenylazetidin-2-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One